Lymphatic filariasis: managing morbidity and preventing disability: an aide-mémoire for national program managers, 2nd ed. World Health Organization, 2021 Overview: Since the first edition
Safety in administering medicines for neglected tropical diseases. World Health Organization, 2021 Overview: The objective of this manual is to provide practical tools, including
Determination, innovation and adaptation can keep lymphatic filariasis elimination on track October 21, 2021 World Health Organization COVID-19 has severely disrupted the implementation of
Progress in eliminating onchocerciasis in the WHO Region of the Americas: disruption of ivermectin mass drug administration in the Yanomami focus area due to
Authors: Emily Toubali, Molly Brady, Ernest Mensah, Aryc Mosher, Emily Wainwright, Liz Eddy, Aria Gray, and Alyssa Jordan Multi-country experiences in implementing a direct
Authors: Elizabeth Fitch, Alison Krentel, Kevin Bardosh, Beth Sutherland, Alyssa Jordan, and Margaret Baker The World Health Organization’s 2021-2030 NTD Road Map advocates for
Part of the Act to End NTDS | East technical brief series June 2021. To eliminate human onchocerciasis transmission of the filarial parasite Onchocerca
Onchocerciasis: diagnostic target product profile to support preventive chemotherapy. WHO, 2021. Overview Onchocerciasis, also known as river blindness, affects an estimated 21 million people,
Video recordings from “The Power of Partnership: Defeating Onchocerciasis” symposium are ready to view. Featuring 29 speakers from diverse aspects of the campaign, the
Déclaration du Comité d’Experts de Mectizan (CEM) sur l’utilisation du Mectizan® : Le Comité rappelle à nos pays partenaires que le Mectizan® est exclusivement
